Augmented 17α‐hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21‐hydroxylase activity in patients with incidentally discovered adrenal tumours ('incidentalomas')
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Summary: OBJECTIVE Recent studies have indicated that the syndrome of congenital adrenal hyperplasia due to 21‐hydroxylase deficiency is closely associated with the development of benign adrenocortical tumours. Tumour formation is thought to be a consequence of ACTH hypersecretion which results from the lack of glucocorticoid synthesis. The aim of this study was to evaluate 21‐hydroxylase activity in patients with an incidentally discovered adrenal mass ('Incidentaloma') without a history of congenital adrenal hyperplasia. DESIGN A prospective study of 52 patients admitted to a single hospital. PATIENTS Fifty‐two consecutive subjects (mean age 56·0 years, range 24–81 years) with an incidentally discovered adrenal tumour were studied. MEASUREMENTS The 21‐hydroxylase reserve was assessed by intravenous bolus administration of 1‐24 ACTH (tetracosactrin) with measurement of basal and stimulated serum 17α‐hydroxyprogesterone (17‐OHP) concentrations. Impaired 21‐hydroxylase activity was defined as an exaggerated 17‐OHP response, with a 17‐OHP increment exceeding 7‐9nmolll. Basal and stimulated cortisol concentrations, and basal ACTH were also measured. RESULTS Baseline levels of 17‐OHP were normal in 44 and elevated in 8 subjects. In 37 patients (71·2%), the 17‐OHP increment following ACTH administration exceeded 7·9nmol/l, demonstrating mildly decreased 21‐hydroxylase activity. In these subjects, the peak serum 17‐OHP correlated with the tumour diameter. In the patients with apparently normal 21‐hydroxylase activity, no significant correlation was found between 17‐OHP concentrations and tumour size. All patients had a stimulated serum cortisol above 550 nmol/l reflecting intact adrenal gluco‐corticoid reserve. There were no other differences between the group with exaggerated and the group with normal 17‐OHP Increment. The tumours were removed from two women with augmented 17‐OHP responses and this was followed by normalization of 17‐OHP dynamics. CONCLUSIONS Biochemical evidence for partial 21‐hydroxyiase defiency is a common finding in patients with an adrenal Incidentaloma, even in the absence of a congential adrenal hyperpiasia history. Exaggerated 17‐OHP increment is not accompanied by decreased adrenal glucocorticoid reserve. Normalization of the 17‐OHP response after surgical treatment suggests that the phenomenon results from reduced 21‐hydroxyiase activity in the tumour, which retains ACTH responsiveness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genotyping steroid 21-hydroxylase deficiency: hormonal reference data
NEW, M. I., LORENZEN, F., LERNER, A. J., KOHN, B., OBERFIELD, S. E., POLLACK, M. S., DUPONT, B., STONER, E., LEVY, D. J., PANG, S., et al. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-320 · Cited by 624
Pang, S., Wallace, M. A., Hofman, L., Thuline, H. C., Dorche, C., Lyon, I. C. T., Dobbins, R. H., Kling, S., Fujieda, K., & Suwa, S. (1988) · Journal of Urology · doi:10.1016/s0022-5347(17)42164-1 · Cited by 392
Nonfunctioning adrenal masses: incidental discovery on computed tomography
Glazer, H., Weyman, P., Sagel, S., Levitt, R., & McClennan, B. (1982) · American Journal of Roentgenology · doi:10.2214/ajr.139.1.81 · Cited by 347
Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia.
Jaresch, S., Kornely, E., Kley, H. K., & Schlaghecke, R. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.3.1311000 · Cited by 227 · cited 1×
“In patients suffering from adrenocortical tumour who were known to be homozygous or heterozygous for CAH, no correlation was seen between serum 17-OHP concentrations and tumour size (Jaresch et al., 1992).”
BackgroundSelf-citation
Cited by
A Survey on Adrenal Incidentaloma in Italy
Mantero, F. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.637 · Cited by 855
Prevalence and natural history of adrenal incidentalomas
Barzon, L., Sonino, N., Fallo, F., Palu, G., & Boscaro, M. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490273 · Cited by 642
Sherlock, M., Scarsbrook, A., Abbas, A., Fraser, S., Limumpornpetch, P., Dineen, R., & Stewart, P. M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa008 · Cited by 347
“A large number of clinical studies have investigated the characteristics of AIs (Table 3 (39, 40,42,46-84)).”
BackgroundLong-term follow-up study of patients with adrenal incidentalomas.
Libe, R., Dall'Asta, C., Barbetta, L., Baccarelli, A., Beck-Peccoz, P., & Ambrosi, B. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1470489 · Cited by 215
Subclinical Cushing’s syndrome in adrenal incidentalomas
Terzolo, M., Bovio, S., Reimondo, G., Pia, A., Osella, G., Borretta, G., & Angeli, A. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.008 · Cited by 179
Metadata
- Authors
- Seppel, T., & Schlaghecke, R.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 1994-10
- Volume
- 41
- Issue
- 4
- Pages
- 445-451
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2035379543
- Cited by
- 63
- References
- 5
- FWCI
- 2.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Augmented 17α‐hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21‐hydroxylase activity in patients with incidentally discovered adrenal tumours ('incidentalomas'). https://app.cochat.ai/papers/10.1111/j.1365-2265.1994.tb02575.x
- The paper
- Seppel, T., & Schlaghecke, R. (1994). Augmented 17α‐hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21‐hydroxylase activity in patients with incidentally discovered adrenal tumours ('incidentalomas'). Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.1994.tb02575.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.